What is AnaptysBio, Inc.'s investment purchases?

AnaptysBio, Inc. (ANAB) reported investment purchases of $0 in Q1 2026.

How has AnaptysBio, Inc.'s investment purchases changed year-over-year?

AnaptysBio, Inc.'s investment purchases decreased by 100.0% year-over-year, from $122.55M to $0.

What is the long-term trend for AnaptysBio, Inc.'s investment purchases?

Over 4 years (2021 to 2025), AnaptysBio, Inc.'s investment purchases has grown at a 13.4% compound annual growth rate (CAGR), from $118.66M to $196.41M.

What does investment purchases mean?

Cash spent purchasing investment securities across all categories.

AnaptysBio, Inc. ANAB Investment Purchases

Investment Purchases at other companies

Eli LillyLLY

$297M+50.8%

BiogenBIIB

$748.8M—

Gilead SciencesGILD

$525M—

Dianthus TherapeuticsDNTH

$238.59M+254%

BridgeBio PharmaBBIO

$52.67M—

PrecigenPGEN

$33.87M+225%

Other financials

Income statement

See full

Revenue$25.6M-8.0%

Operating income-$34.6M-25.8%

Net income-$52.9M-34.5%

EPS (diluted)-$1.84-43.8%

Balance sheet

See full

Cash & equivalents$248.5M+152%

Total debt$13.6K-99.9%

Total equity$12.7M-62.5%

Total assets$329.7M-21.9%

Cash flow

See full

Operating cash flow-$25.9M-142%

CapEx$17.0K-51.4%

Free cash flow-$25.9M-142%

Valuation

See full

Market cap$1.73B+180%

Enterprise value$1.48B+176%

P/S7.4×+1.9×

Profitability

See full

Operating margin17.6%+9.6pp

Net margin-49.9%-22.6pp

FCF margin1.9%+1.0pp

Returns & leverage

See full

Return on equity-343.8%-1,012pp

Debt / equity0×-0.5×

Current ratio7.6×-0.7×

Where this comes from

Reported directly by AnaptysBio, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt.

The official record: AnaptysBio, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about AnaptysBio, Inc.'s investment purchases.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is AnaptysBio, Inc.'s investment purchases?: AnaptysBio, Inc. (ANAB) reported investment purchases of $0 in Q1 2026.
How has AnaptysBio, Inc.'s investment purchases changed year-over-year?: AnaptysBio, Inc.'s investment purchases decreased by 100.0% year-over-year, from $122.55M to $0.
What is the long-term trend for AnaptysBio, Inc.'s investment purchases?: Over 4 years (2021 to 2025), AnaptysBio, Inc.'s investment purchases has grown at a 13.4% compound annual growth rate (CAGR), from $118.66M to $196.41M.
What does investment purchases mean?: Cash spent purchasing investment securities across all categories.